As We Wave Goodbye to the Waiver! - Frankly Speaking Ep 327
b"Credits: 0.25 AMA PRA Category 1 Credit\\u2122\\xa0CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-327\\nOverview: Congress has recently made changes to help fight the opioid epidemic and allow for an increase in access to treatment for opioid use disorder (OUD). Join us as we review these changes, and learn how you can use them to promote health equity in a clinical setting.\\nEpisode resource links:\\nHawk, K., Hoppe, J., Ketcham, E., LaPietra, A., Moulin, A., Nelson, L., ... & D\\u2019Onofrio, G. (2021). Consensus recommendations on the treatment of opioid use disorder in the emergency department. Annals of emergency medicine, 78(3), 434-442.\\n\\nJones, K. F., O'Reilly-Jacob, M., & Tierney, M. (2022). Eliminating the buprenorphine DEA X waiver is critical to promote health equity. Nursing outlook, 70(1), 5-7.\\n\\n\\nJones, K. F. , Jacob, M. O. , Spetz, J. , Hailer, L. & Tierney, M.\\xa0 (9000). Eliminate the buprenorphine DEA X waiver: Justification using a policy analysis approach.\\xa0 Journal of Nursing Scholarship,\\xa0 , doi: 10.1111/jnu.12871.\\n\\nGuest: Mariyan L. Montaque, DNP, FNP-BCMusic Credit: Richard Onorato"